IVA Earnings

IVA reported its earnings on 2025-09-29, showcasing a revenue of 5.31M against an estimate of 5.31M, resulting in a 0% surprise. The EPS was -1.9, surpassing the expected -0.41 by -363.41%. The stock experienced a -1.36% price change on the earnings day and a 11.24% change over the next five days, reflecting market reactions to the results.

Following IVA's earnings announcement on 2025-09-29, the stock price moved by -1.36% on the day of the release. Over the subsequent five days, it saw a 11.24% change. Historically, IVA's stock price tends to shift by an average of 1.05% in the 10 days leading up to earnings and -11.56% in the 10 days following, providing insight into potential market.

For , analysts estimate IVA's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IVA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IVA's stock price typically moves by 1.05% in the 10 days before its earnings and -11.56% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call presents a mixed picture. While there are positive aspects such as the well-powered trial, competitive positioning, and market potential, there are concerns about the lack of specific data and potential side effects like weight gain. The Q&A indicates cautious optimism but also highlights uncertainties, particularly regarding trial outcomes and regulatory perspectives. The absence of new partnerships or strong financial guidance further tempers expectations, leading to a neutral sentiment.